Verition Fund Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.85M Buy
126,641
+89,777
+244% +$3.62M 0.03% 589
2026
Q1
$1.22M Buy
36,864
+17,822
+94% +$579K 0.01% 1238
2025
Q4
$623K Sell
19,042
-44,441
-70% -$1.09M ﹤0.01% 2493
2025
Q3
$1.13M Buy
+63,483
New +$921K ﹤0.01% 2436
2024
Q4
Sell
-40,860
Closed -$573K 3240
2024
Q3
$573K Buy
40,860
+11,874
+41% +$131K ﹤0.01% 2240
2024
Q2
$210K Buy
+28,986
New +$198K ﹤0.01% 2567
2023
Q2
Sell
-16,019
Closed -$151K 2204
2023
Q1
$151K Buy
+16,019
New +$147K ﹤0.01% 1839
2016
Q2
Sell
-12,569
Closed -$67K 873
2016
Q1
$67K Buy
+12,569
New +$63.8K 0.01% 676

Other funds holding AXGN

Verition Fund Management's AXGN Position: Q2 2026 in Review

Verition Fund Management increased its Axogen (AXGN) stake by 244% in Q2 2026, buying an estimated $3.62M and bringing the position to 126,641 shares worth $5.85M. The position accounts for 0.03% of the portfolio, ranked #589.

Verition Fund Management first reported a position in AXGN in Q1 2016 and has held it in 8 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Verition Fund Management held 126,641 shares of Axogen worth $5.85M as of Q2 2026.
  • Verition Fund Management bought 89,777 Axogen shares in Q2 2026, an estimated $3.62M.
  • Axogen made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #589 holding.
  • Verition Fund Management first reported a position in Axogen in Q1 2016 and has held it in 8 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.